Sandoz Group AG Company Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.

It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Sandoz Group AG

Country	Switzerland
Founded	1886
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	22,633
CEO	Richard Saynor

Contact Details

Address: Forum 1 Basel, 4056 Switzerland
Phone	41 61 324 11 11
Website	sandoz.com

Stock Details

Ticker Symbol	SDZ
Exchange	SIX Swiss Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CH1243598427
SIC Code	2834

Key Executives

Name	Position
Richard Saynor	Chief Executive Officer
Remco J. Steenbergen	Chief Financial Officer
Asaf Gal	Chief Technology Officer
Claire D'Abreu-Hayling	Chief Scientific Officer
Karen M. King	Head Global Investor Relations
Ingrid Sollerer	General Counsel and Chief Compliance Officer
Tripti Jha	Chief People Officer
Francisco Ballester	President of International
Dr. Glenn A. Gerecke Ph.D.	Chief Manufacturing and Supply Officer
Rebecca Guntern	Chief Commercial Officer